Statistics

Total Visits

Views
Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): A randomized, noninferiority phase II trialwith a pharmacogenetic analysis67

Select a period of time:

Number of views in the range

Views
Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): A randomized, noninferiority phase II trialwith a pharmacogenetic analysis29

Views

Views
July 202517
August 20254
September 20252
October 20250
November 20250
December 20256
January 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil13
United States5
United Kingdom3
Ecuador2
Germany1
Ireland1
Morocco1
Singapore1
Turkey1
Trinidad and Tobago1
 

Top cities views

Views
São Paulo2
Belo Horizonte2
Ashburn1
Balneário Camboriú1
Birmingham1
Bluffton1
Dallas1
Dublin1
Edwardsville1
Frankfurt am Main1